Low PSA metastatic androgen-independent prostate cancer

European Urology

Volumn 38, Issue 3, 2000, Pages 250-254

  Sella, Avishay ^a   Konichezky, M ^a   Flex, D ^a   Sulkes, A ^a   Baniel, J ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Low PSA; Neuroendocrine; Poorly differentiated cancer; Prostate cancer; Small cell cancer

Indexed keywords

ANDROGEN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; DOXORUBICIN; ESTRAMUSTINE; ETOPOSIDE; METHOTREXATE; PROSTATE SPECIFIC ANTIGEN; VINBLASTINE;

ARTICLE; BONE METASTASIS; CHEMOSENSITIVITY; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS; NEUROENDOCRINE TUMOR; PELVIS TUMOR; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; SMALL CELL CARCINOMA; TISSUE DIFFERENTIATION;

EID: 0033839917     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020289     Document Type: Article

References (21)